V
Vincent Cottin
Researcher at Claude Bernard University Lyon 1
Publications - 675
Citations - 29630
Vincent Cottin is an academic researcher from Claude Bernard University Lyon 1. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 68, co-authored 574 publications receiving 21594 citations. Previous affiliations of Vincent Cottin include University of Lyon & Institut national de la recherche agronomique.
Papers
More filters
Journal ArticleDOI
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis
Giacomo Emmi,Alessandra Bettiol,Elena Gelain,Ingeborg M. Bajema,Alvise Berti,Stella Burns,Maria C. Cid,Jan Willem Cohen Tervaert,Vincent Cottin,E. Durante,Alfred Mahr,M Martinez Del Pero,Chiara Marvisi,John Mills,Sergey Moiseev,Chetan Mukhtyar,Thomas Neumann,Iacopo Olivotto,Carlo Salvarani,Benjamin Seeliger,Renato Alberto Sinico,Camille Taillé,Benjamin Terrier,Nils Venhoff,George Bertsias,Loïc Guillevin,David Jayne,Augusto Vaglio +27 more
TL;DR: In this article , the authors present evidence-based, cross-discipline guidelines for the diagnosis and management of EGPA that reflect the substantial advances that have been made in the past few years in understanding the pathogenesis, clinical subphenotypes and differential diagnosis of the disease, as well as the availability of new treatment options.
Journal ArticleDOI
Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France.
Vincent Cottin,Sophie Larrieu,Loic Boussel,Salim Si-Mohamed,Fabienne Bazin,Sébastien Marque,Jacques Massol,Françoise Thivolet-Béjui,Lara Chalabreysse,Delphine Maucort-Boulch,Stéphane Jouneau,Eric Hachulla,J. Chollet,Mouhamad Nasser +13 more
TL;DR: In this paper, the authors investigated the clinical characteristics, epidemiology, survival estimates and healthcare resource utilization and associated costs in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) in France.
Journal ArticleDOI
The European Respiratory Review: farewell from the editor with confidence for the future
TL;DR: As my third year as Chief Editor of the European Respiratory Review comes to an end, it is time to pass this responsibility onto a new team and look back at what has been accomplished and what challenges are faced.
Proceedings ArticleDOI
Treatment of pulmonary arterial hypertension in elderly and very elderly patients
Marylise Ginoux,Ségolène Turquier,Julie Traclet,Chahéra Khouatra,François Philit,Agathe Sénéchal,Jean-Charles Glerant,Jean-François Mornex,Jean-François Cordier,Vincent Cottin +9 more
TL;DR: Very elderly patients have a response and safety profile to PAH treatment less favourable than younger patients, the clinical and hemodynamic benefit seems to be reduced, and the risk of adverse effects may be more frequent.
Journal ArticleDOI
Efficacy of Pirfenidone vs. Placebo in Unclassifiable Interstitial Lung Disease, by Surgical Lung Biopsy Status: Data From a post-hoc Analysis
Maria Molina-Molina,Michael Kreuter,Vincent Cottin,Tamera J. Corte,F. Gilberg,Klaus-Uwe Kirchgaessler,Judit Axmann,Toby M. Maher +7 more
TL;DR: The results from the post-hoc analysis identified that pirfenidone may be an effective treatment in progressive fibrosing uILD over 24 weeks, irrespective of SLB status; however, caution should be taken when interpreting these data due to several limitations.